pharmadog

News

when

Latest
Archive

by source

All Sources
Sources Page

Jobs

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

made by humans and a good dog

home
jobs
news
search

calendar

18,993 catalysts · 18,987 approval · 5,811 phase readout · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

hide past →

sort

soonest latest type sponsor alpha

type: filing×type: approval×clear all

type

approval18,987
phase readout5,811
device 510k5,000
grant4,728
8k filing2,984
device pma2,000
device recall

2,000

recall1,126

device adverse event1,000

earnings520

therapy area

Ophthalmology5

Week of Nov 24, 2014

›Nov 25, 2014approval4274d agoBOSULIF (BOSUTINIB MONOHYDRATE) — FDA approvalAlembic Pharmaceuticals Inc

Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Nov 25, 2014approval4274d agoPRIFTIN (RIFAPENTINE) — FDA approvalrifapentine

Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

full page →rifapentine →fda approvals ↗

›Nov 28, 2014approval4271d agoDICLOFENAC SODIUM — FDA approvalDICLOFENAC SODIUM

Sponsor: AUROBINDO PHARMA USA. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →DICLOFENAC SODIUM →fda approvals ↗

›Nov 28, 2014approval4271d agoRISPERIDONE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗

Week of Dec 1, 2014

›Dec 1, 2014approval4268d agoTOPIRAMATE — FDA approvaltopiramate ER

Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL

full page →topiramate ER →fda approvals ↗

›Dec 2, 2014approval

Week of Dec 8, 2014

›Dec 8, 2014approval4261d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

›Dec 8, 2014approval

← prev

page 147 of 380

4267d ago

CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER (NICARDIPINE HYDROCHLORIDE) — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: CHIESI. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

›Dec 2, 2014approval4267d agoACTONEL (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

Sponsor: APIL. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 3, 2014approval4266d agoBLINCYTO (BLINATUMOMAB) — FDA approvalblinatumomab

Sponsor: AMGEN. Form: INJECTABLE. Route: INJECTION

full page →blinatumomab →fda approvals ↗

›Dec 4, 2014approval4265d agoIDARUBICIN HYDROCHLORIDE — FDA approvalIDARUBICIN HYDROCHLORIDE

Sponsor: PFIZER. Form: SOLUTION. Route: INTRAVENOUS

full page →IDARUBICIN HYDROCHLORIDE →fda approvals ↗

›Dec 5, 2014approval4264d agoABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalaripiprazole LA

Sponsor: OTSUKA PHARM CO LTD. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

full page →aripiprazole LA →fda approvals ↗

›Dec 5, 2014approval4264d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

›Dec 5, 2014approval4264d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

›Dec 5, 2014approval4264d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

›Dec 5, 2014approval4264d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

›Dec 5, 2014approval4264d agoHEPARIN SODIUM — FDA approvalHEPARIN SODIUM

Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

full page →HEPARIN SODIUM →fda approvals ↗

4261d ago

CLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 8, 2014approval4261d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 8, 2014approval4261d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 8, 2014approval4261d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 8, 2014approval4261d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗

›Dec 8, 2014approval4261d agoOLANZAPINE — FDA approvalTorrent Pharma Inc

Sponsor: TORRENT PHARMS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 8, 2014approval4261d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

›Dec 8, 2014approval4261d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

›Dec 8, 2014approval4261d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: AUROBINDO PHARMA. Form: SOLUTION. Route: ORAL

full page →ondansetron hydrochloride CR →fda approvals ↗

›Dec 8, 2014approval4261d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: AUROBINDO PHARMA. Form: SOLUTION. Route: ORAL

full page →ondansetron hydrochloride CR →fda approvals ↗

›Dec 10, 2014approval4259d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

›Dec 10, 2014approval4259d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

›Dec 10, 2014approval4259d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 10, 2014approval4259d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 10, 2014approval4259d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

›Dec 10, 2014approval4259d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

›Dec 10, 2014approval4259d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

›Dec 10, 2014approval4259d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

›Dec 10, 2014approval4259d agoONDANSETRON — FDA approvalondansetron ODT

Sponsor: SANDOZ. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →ondansetron ODT →fda approvals ↗

›Dec 10, 2014approval4259d agoONDANSETRON — FDA approvalondansetron ODT

Sponsor: SANDOZ. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →ondansetron ODT →fda approvals ↗

›Dec 11, 2014approval4258d agoKALYDECO (IVACAFTOR) — FDA approvalVertex, Inc.

Sponsor: VERTEX PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 11, 2014approval4258d agoZUBSOLV (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalEdenbridge Pharmaceuticals LLC

Sponsor: EDENBRIDGE PHARMS. Form: TABLET. Route: SUBLINGUAL

full page →fda approvals ↗

›Dec 11, 2014approval4258d agoLINZESS (LINACLOTIDE) — FDA approvallinaclotide

Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL

full page →linaclotide →fda approvals ↗

›Dec 12, 2014approval4257d agoLAMOTRIGINE — FDA approvalAlembic Pharmaceuticals Inc

Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 12, 2014approval4257d agoLAMOTRIGINE — FDA approvalAlembic Pharmaceuticals Inc

Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 12, 2014approval4257d agoLAMOTRIGINE — FDA approvalAlembic Pharmaceuticals Inc

Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 12, 2014approval4257d agoLAMOTRIGINE — FDA approvalAlembic Pharmaceuticals Inc

Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 12, 2014approval4257d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

›Dec 12, 2014approval4257d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

›Dec 12, 2014approval4257d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

›Dec 12, 2014approval4257d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

›Dec 12, 2014approval4257d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

›Dec 13, 2014approval4256d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Dec 13, 2014approval4256d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

$AMRX18.14+0.39%

$RDY12.22+0.91%

$PFE26.76+2.14%

$VERX11.94+3.20%

$AMRX18.14+0.39%

$ABBV246.04+0.89%

$PFE26.76+2.14%

$AMGN410.94+1.51%